IRIS
PORRECA, Ettore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.507
EU - Europa 5.301
AS - Asia 5.065
SA - Sud America 712
AF - Africa 60
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 12
Totale 18.678
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.351
SG - Singapore 1.994
CN - Cina 1.626
UA - Ucraina 912
IE - Irlanda 884
SE - Svezia 777
IT - Italia 650
TR - Turchia 637
GB - Regno Unito 613
BR - Brasile 612
DE - Germania 414
FR - Francia 390
IN - India 238
VN - Vietnam 223
FI - Finlandia 212
RU - Federazione Russa 189
CA - Canada 100
HK - Hong Kong 70
PL - Polonia 53
AR - Argentina 48
MX - Messico 40
BE - Belgio 39
BD - Bangladesh 38
JP - Giappone 38
ES - Italia 37
NL - Olanda 30
SA - Arabia Saudita 29
KR - Corea 27
EC - Ecuador 25
TW - Taiwan 25
ZA - Sudafrica 25
AT - Austria 22
AU - Australia 19
ID - Indonesia 19
IQ - Iraq 15
CZ - Repubblica Ceca 14
GR - Grecia 12
EU - Europa 11
IL - Israele 11
IR - Iran 11
RO - Romania 10
JO - Giordania 9
KE - Kenya 9
LT - Lituania 9
PK - Pakistan 9
MA - Marocco 6
PY - Paraguay 6
VE - Venezuela 6
EG - Egitto 5
MY - Malesia 5
TH - Thailandia 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
DZ - Algeria 4
NO - Norvegia 4
NP - Nepal 4
TN - Tunisia 4
AL - Albania 3
BO - Bolivia 3
CH - Svizzera 3
CL - Cile 3
DO - Repubblica Dominicana 3
EE - Estonia 3
HN - Honduras 3
HR - Croazia 3
JM - Giamaica 3
KH - Cambogia 3
PE - Perù 3
PS - Palestinian Territory 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SR - Suriname 3
CI - Costa d'Avorio 2
CO - Colombia 2
CU - Cuba 2
ET - Etiopia 2
LB - Libano 2
LK - Sri Lanka 2
PH - Filippine 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
GD - Grenada 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
Totale 18.668
Salva come PNG Salva come JPEG
Città #
Singapore 1.469
Chandler 1.099
Jacksonville 1.040
Dublin 869
Princeton 437
Beijing 408
Southend 385
Ashburn 371
Dallas 336
Izmir 326
Nanjing 290
Dearborn 247
Wilmington 222
Los Angeles 199
Santa Clara 193
Cambridge 170
The Dalles 149
Altamura 138
Ann Arbor 131
Chieti 130
Tongling 128
Buffalo 103
Nanchang 98
New York 96
Ho Chi Minh City 83
Boardman 81
Munich 81
Woodbridge 81
São Paulo 80
Hebei 65
Hong Kong 65
Shenyang 54
Kunming 48
Redondo Beach 45
Houston 43
Jiaxing 43
Council Bluffs 42
Tianjin 42
Hanoi 41
Helsinki 41
Washington 35
Brussels 32
Grevenbroich 32
Tokyo 31
Hefei 30
Pescara 30
Warsaw 30
Changsha 28
Hangzhou 28
San Mateo 28
Montreal 27
Seattle 27
Brooklyn 26
Riyadh 26
Norwalk 25
Poplar 25
Falls Church 24
Stockholm 24
Denver 22
Jinan 22
Guangzhou 21
Leawood 20
Phoenix 20
Rio de Janeiro 20
San Francisco 20
Toronto 20
Augusta 19
Chicago 19
Nuremberg 19
Boston 18
Atlanta 17
Chennai 17
Orem 17
Amsterdam 16
Milan 16
Orange 16
Johannesburg 15
London 15
Moscow 15
Dong Ket 14
Ningbo 14
Seoul 14
Taipei 14
Turku 14
Ankara 13
Belo Horizonte 13
Porto Alegre 13
Auburn Hills 12
Kocaeli 12
Lanzhou 12
Manchester 12
Sydney 12
Vienna 12
Montesilvano Marina 11
Querétaro 11
Teramo 11
Hamilton 10
Hanover 10
Kraków 10
Paris 10
Totale 11.115
Salva come PNG Salva come JPEG
Nome #
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism 292
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study 218
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 157
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 149
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 144
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 141
Effect of MK-571, a selective leukotriene D4 receptor antagonist, on vascular smooth muscle cell proliferation and interleukin 1 release 141
Aortic antioxidant defence mechanisms: time-related changes in cholesterol-fed rabbits. 139
Reduced variability to aspirin antiplatelet effect by the coadministration of statins in high-risk patients for cardiovascular disease. 139
Pravastatin upregulates TGF-b1 in THP-1 human macrophage: effect on scavenger receptor class A expression. 130
AORTIC ANTIOXIDANT DEFENSE MECHANISMS IN RABBITS SUBJECTED TO SUPRARENAL AORTIC COARCTATION HYPERTENSION 126
Impaired enzymatic reactive aldehyde-detoxifying capacity and glutathione peroxidase activity in the aged human arterial tissue 126
Circadian variations in antioxidant defences and lipid peroxidation in the rat heart 125
Angiotensin-converting enzyme inhibitors counteract hypoxia-induced coronary constriction in the isolated rat heart 121
Apixaban for extended treatment of venous thromboembolism 120
INCREASED TYPE I AND TYPEII TRANSFORMING GROWTH FACTOR-β RECEPTOR EXPRESSION DURING CHOLESTEROL CHALLENGE. 119
Haemostatic abnormalities, cardiac involvement and serum tumor necrosis factor levels in X-linked dystrophic patients. 119
Circulating leptin is associated with oxidized LDL in postmenopausal women. 119
Ambulatory Blood Pressure Parameters and Heart Failure With Reduced or Preserved Ejection Fraction in Elderly Treated Hypertensive Patients 119
Cholesterol feeding modulates type I and type II TGF-beta receptor expression and fibrogenic vascular remodelling in C57BL/6 mice (pubbl. su Atherosc.) 118
Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese patients. 118
Circadian blood pressure changes and cardiovascular risk in elderly-treated hypertensive patients 118
Increased expression of transforming growth factor beta isoforms by human monocytes of hypertensive patients 118
Metabolic Syndrome and Cardiovascular Risk in Elderly Treated Hypertensive Patients. 115
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 113
Human interleukin 1 receptor antagonist (IL-1RA) inhibition of inducible thromboxane B2 generation in human monocytes 112
Study of the gastric mucosal reactivity in patients with urticaria induced by nonsteroidal anti-inflammatory drugs. 111
Combined effect of glucose and insulin in stimulating plasminogen activator inhibitor-1 secretion and gene expression in human vascular smooth muscle cells in culture 111
Reversal of P-glycoprotein-mediated multidrug resi stance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs 111
Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension 111
Oral rivaroxaban for symptomatic venous thromboembolism 111
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 110
Antioxidant metabolic mechanisms in hypertensive and atherosclerotic arterial wall 110
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 110
Increased type II transforming growth factor-beta receptor expression in liver cells during cholesterol challenge 109
Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo. 109
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. 109
ISOXAZOLE DERIVATIVES AND THEIR USE AS CYCLOOXYGENASE INHIBITORS 109
[Physiopathological bases of the medical treatment of portal hypertension]. 109
Aortic antioxidant defence mechanisms during the progression of atherosclerosis in cholesterol-fed rabbits 109
Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease 108
Antiproliferative effect of deferoxamine on vascular muscle cells in vitro and in vivo. 108
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis 108
Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization 108
Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation 108
Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. 107
Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review 107
PRAVASTATIN UP-REGULATES TGF-B1 IN THP-1 HUMAN MACROPHAGES :EFFECT ON SCAVENGER RECEPTOR CLASS A EXPRESSION 106
Modulatory effects of heparin on cellular accumulation and cytotoxicity of doxorubicin in MRP1-overexpressing HL60/doxo cells. 106
Prognostic value of nondipping and morning surge in elderly treated hypertensive patients with controlled ambulatory blood pressure 106
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 105
Glutathione-related enzyme activities and lipoperoxide levels in human internal mammary artery and ascending aorta. Relations with serum lipids 105
Morning Blood Pressure Surge, Dipping, and Risk of Coronary Events in Elderly Treated Hypertensive Patients 105
Down regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes. 104
Oral apixaban for the treatment of acute venous thromboembolism 104
Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. 103
Identification of three genetic risk factors for venous thrombosis using a multiplex allele-specific PCR assay: comparison of conventional and new alternative methods for the preparation of DNA from clinical samples 103
Antioxidant properties of ticlopidine on human low density lipoprotein oxidation 103
Effect of interleukin-1 receptor antagonist (IL-1RA) on vascular smooth muscle cell proliferation (VSMC). 102
IS THE SIMPLEST EXPLANATION USUALLY THE CORRECT ONE? A CLINICAL APPLICATION OF THE "OCKHAM'S RAZOR" 102
Monocyte chemoattractant protein-1 as a mitogen for vascular smooth muscle cell 101
Transforming growth factor beta1 induces IL-1 receptor antagonist gene expression and production in rat vascular smooth muscle cells 101
Increased Plasminogen Activator Inhibitor (PAI-1) Synthesis and Gene Expression in Adipocyte of Diabetic Rats 101
Transforming growth factor beta1 induces IL-1 receptor antagonist production and gene expression in rat vascular smooth muscle cells 101
Rivaroxaban or aspirin for extended treatment of venous thromboembolism 101
CYCLOOXYGENASE-2-DERIVED PROSTACYCLIN RESTRAIN PLATELET THROMBOXANE BIOSYNTHESIS IN TOLL-LIKE RECEPTOR 4 POLYMORPHISM 100
Non-O blood group and outcomes of in vitro fertilization 100
Determinants of platelet activation in Alzheimer's disease 100
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis 100
Gastrointestinal manifestations of SARS-CoV-2 infection in an Italian population of hospitalized patients 100
Synergic effect of glucose and insulin in stimulating plasminogen activator inhibitor 1 (PAI-1) expression and secretion in human vascular smooth cells (vSMC) 99
Infra-red laser irradiation enhances interleukin-1 receptor antagonist, increase 3H-thymidine incorporation and the release of 3H arachidonic acid in human macrophages 99
Myocardial antioxidant defence mechanisms: time-related changes after reperfusion of the ischemic rat heart 99
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 99
Inhibition of P-glycoprotein mediated transport by S-adenosylmethionine and Cynarin in multidrug resistant human uterine sarcoma MES-SA/Dx5 cells. 98
Rivaroxaban for cancer-associated cardiac thrombosis 98
Dementia in patients with atrial fibrillation and the value of the Hachinski ischemic score 98
Increased transforming growth factor-beta production and gene expression by peripheral blood monocytes of hypertensive patients. 97
Cysteinyl-leukotriene D4 induced IL-1 beta expression ans release in rat vascular smooth muscle cells. 97
Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness 97
Association of Factor VII Levels With Inflammatory Parameters in Hypercholesterolemic Patients. 96
The effect of the plasticizer diethylhexyl phthalate on transport activity and expression of P-glycoprotein in parental and doxo-resistant human sarcoma cell lines. 96
Systemic oxidative stress status in patients with ischemic heart disease 96
Evidence for oxidative and not reductive stress in the aged rabbit heart 95
Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis 95
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19 95
The hematocrit and platelet target in polycytemia vera 94
Prognosis of Masked and White Coat Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring in Elderly Treated Hypertensive Patients 94
New method for the extraction of DNA from white blood cells for the detection of common genetic variants associated with thrombophilia 93
Regional distribution of glutathione-related antioxidant defences in the normal rabbit aorta. 93
Induction of alkaline phosphatase generation by IL-1ß and LPS on human neutrophils and macrophages and lack of inhibition by interleukin-1 receptor antagonist. 93
Effect of aortic coarctation hypertension on the antioxidant defense mechanisms in the rabbit aorta 93
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. 93
Iron status and oxidative stress in the aged rabbit heart 93
Effects of body composition on the procoagulant imbalance in obese patients 93
Effect of high fat-, cholesterol-enriched diet on the antioxidant defence mechanisms in the rabbit heart 92
Protein kinase C pathway and proliferative response of aged and young rat vascular smooth muscle cell. 91
“ISOXAZOLE DERIVATIVES AND THEIR USE AS CYCLOOXYGENASE INHIBITORS" 91
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 91
Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients 91
Totale 11.057
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.311
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.311
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021736 0 0 0 0 0 268 15 20 97 163 79 94
2021/20221.026 53 13 11 236 77 24 25 81 68 17 101 320
2022/20233.091 261 403 179 331 303 627 174 226 404 39 88 56
2023/20241.369 94 48 124 45 108 391 296 55 31 38 7 132
2024/20253.640 241 625 537 56 65 138 90 175 401 223 461 628
2025/20263.443 660 375 686 887 721 114 0 0 0 0 0 0
Totale 19.252